|
|||||
![]() |
|
Consumer products behemoth Proctor & Gamble (NYSE:PG) met Wall Street’s revenue expectations in Q2 CY2025, with sales up 1.7% year on year to $20.89 billion. Its non-GAAP profit of $1.48 per share was 4.1% above analysts’ consensus estimates.
Is now the time to buy PG? Find out in our full research report (it’s free).
Procter & Gamble’s second quarter results met Wall Street’s revenue expectations, but the market responded negatively, reflecting uncertainty around the company’s growth trajectory. Management attributed the flat sales volumes to cautious consumer behavior and a slower category growth environment, particularly in North America and Europe. CEO Jon Moeller specifically highlighted ongoing inventory reductions at retailers and pockets of lost brand superiority in select categories as key challenges. CFO Andre Schulten noted, “Where we have superiority in the Olay lineup like Super Serum, we bring in 65% of business via new users,” emphasizing the need for ongoing innovation to regain momentum.
Looking ahead, Procter & Gamble’s guidance reflects a cautious outlook as management expects continued volatility in consumer demand, tariffs, and overall category growth. The company’s two-year restructuring program aims to streamline the portfolio, enhance supply chain efficiency, and redesign the organization for greater agility. Schulten cautioned that the wide guidance range was necessary due to unpredictable macroeconomic and geopolitical factors, saying, “There’s a level of baseline uncertainty that we reflect in the guidance range.” Management remains focused on creating internal growth drivers through innovation and operational improvements.
Management pointed to broad-based category performance, ongoing innovation, and the launch of a significant restructuring program as central themes in the quarter.
Procter & Gamble expects macroeconomic volatility, tariff impacts, and consumer demand uncertainty to shape its near-term guidance and strategic focus.
Going forward, the StockStory team will monitor (1) progress on restructuring execution and realization of cost savings, (2) the pace of recovery in category growth rates, especially in North America and China, and (3) the consumer response to new product innovations like Tide evo and Pampers Platinum Protection. We will also track the company’s ability to offset tariff and input cost headwinds through pricing and supply chain initiatives.
Procter & Gamble currently trades at $155.08, down from $157.03 just before the earnings. Is there an opportunity in the stock?The answer lies in our full research report (it’s free).
When Trump unveiled his aggressive tariff plan in April 2025, markets tanked as investors feared a full-blown trade war. But those who panicked and sold missed the subsequent rebound that’s already erased most losses.
Don’t let fear keep you from great opportunities and take a look at Top 9 Market-Beating Stocks. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-micro-cap company Kadant (+351% five-year return). Find your next big winner with StockStory today.
StockStory is growing and hiring equity analyst and marketing roles. Are you a 0 to 1 builder passionate about the markets and AI? See the open roles here.
12 hours | |
Sep-14 | |
Sep-13 | |
Sep-13 | |
Sep-12 | |
Sep-11 | |
Sep-11 | |
Sep-10 | |
Sep-10 | |
Sep-08 | |
Sep-08 | |
Sep-08 | |
Sep-05 | |
Sep-04 | |
Sep-04 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite